Fluoxetine hydrochloride
CAS No. 56296-78-7
Fluoxetine hydrochloride( LY110140 )
Catalog No. M15048 CAS No. 56296-78-7
Fluoxetine HCl is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 25MG | 38 | In Stock |
|
| 50MG | 51 | In Stock |
|
| 100MG | 65 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 184 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFluoxetine hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionFluoxetine HCl is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class.
-
DescriptionFluoxetine HCl is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class.(In Vitro):Fluoxetine hydrochloride (LY 110140) blocks the downregulation of cell proliferation resulting from inescapable shock (IS) of hippocampal cell. Fluoxetine increases the number of newborn cells in the dentate gyrus of the hippocampus of adult rat. Fluoxetine also increases the number of proliferating cells in the prelimbic cortex. Fluoxetine accelerates the maturation of immature neurons. Fluoxetine enhances neurogenesis-dependent long-term potentiation (LTP) in the dentate gyrus. Fluoxetine, but not citalopram, fluvoxamine, paroxetine and sertraline, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Fluoxetine produces robust and sustained increases in extracellular concentrations of norepinephrine and dopamine after acute systemic administration. (In Vivo):Fluoxetine hydrochloride (LY 110140) treatment also reverses the deficit in escape latency observed in animals exposed to inescapable shock in adult male Sprague-Dawley rats. Fluoxetine (5 mg/kg) alone increases cell proliferation in the dentate gyrus. Coadministration (fluoxetine 5 mg/kg + olanzapine) also significantly increases the number of BrdU-positive cells compared with the control group. Fluoxetine combined with Olanzapine produces robust, sustained increases of extracellular levels of dopamine ([DA](ex)) and norepinephrine ([NE](ex)) up to 361% and 272% of the baseline, respectively, which are significantly greater than either drug alone.
-
In Vitro——
-
In Vivo——
-
SynonymsLY110140
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT| Sert (Sodium-dependent)
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number56296-78-7
-
Formula Weight345.79
-
Molecular FormulaC17H18F3NO·HCl
-
Purity>98% (HPLC)
-
SolubilityEthanol: 69 mg/mL (199.54 mM); Water: 4 mg/mL (11.56 mM); DMSO: 69 mg/mL (199.54 mM)
-
SMILESCl.CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Richman A, et al. Epilepsy Res. 2007 Apr;74(1):19-27.
molnova catalog
related products
-
P-Hydroxyphenethyl t...
P-Hydroxyphenethyl trans-ferulate exhibits affinity toward 5-HT(7) receptors in a competitive binding assay.
-
Molindone hydrochlor...
Molindone is a therapeutic antipsychotic, used in the treatment of schizophrenia, works by blocking the effects of dopamine in the brain, leading to diminished psychoses.
-
Quetiapin
Quetiapine is indicated for the treatment of schizophrenia as well as for the treatment of acute manic episodes associated with bipolar I disorder.
Cart
sales@molnova.com